ERO1α is a novel endogenous marker of hypoxia in human cancer cell lines.

Norio TakeiAkihiro YonedaMarina KosakaKaori Sakai-SawadaYasuaki Tamura

Published in: BMC cancer (2019)

ERO1α can serve as a novel endogenous chronic hypoxia marker that is more reliable than CA9 and can be used as a diagnostic biomarker and therapeutic target for cancer.

Keyphrases

endothelial cells
papillary thyroid
squamous cell
lymph node metastasis
squamous cell carcinoma
induced pluripotent stem cells
young adults